Pulmonary Tubercolosis - Nursing Case Study

Pathophysiology

• Primary mechanism: Mycobacterium tuberculosis inhalation leads to alveolar macrophage infection, where bacteria evade the immune response by inhibiting phagosome-lysosome fusion, allowing intracellular replication and granuloma formation—a hallmark of latent TB infection.

• Secondary mechanism: In progressive disease, granulomas can liquefy, causing caseous necrosis. This process facilitates bacterial dissemination within the lung and possibly to other organs via hematogenous spread, leading to miliary TB.

• Key complication: Extensive tissue destruction and cavitation in the lungs can result in severe respiratory compromise, hemoptysis, and pulmonary failure, with the potential for extrapulmonary complications like meningitis or disseminated disease.

Patient Profile

Demographics:

45-year-old male, construction worker

History:

• Key past medical history: HIV positive, previous treatment for latent tuberculosis, chronic obstructive pulmonary disease (COPD)

• Current medications: Antiretroviral therapy (combination therapy including tenofovir, lamivudine, and efavirenz), inhaled corticosteroids, bronchodilators

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Severe cough and difficulty breathing

• Key symptoms: Persistent cough with blood-tinged sputum, night sweats, weight loss, chest pain, fever, and chills

• Vital signs: Blood pressure 95/60 mmHg, heart rate 120 bpm, respiratory rate 30 breaths per minute, temperature 102.5°F, oxygen saturation 85% on room air

Section 1

As the healthcare team conducted the initial assessment, the patient's condition was evaluated meticulously. Physical examination revealed increased use of accessory muscles and intercostal retractions, indicating severe respiratory distress. Auscultation of the lungs uncovered diffuse crackles and wheezing, particularly in the upper lobes. Despite aggressive oxygen therapy, the patient’s oxygen saturation remained critically low at 88% on a high-flow nasal cannula, suggesting significant ventilation-perfusion mismatch and potential impending respiratory failure. A comprehensive neurological assessment showed the patient was alert but exhibited mild confusion, likely secondary to hypoxia and fever.

Laboratory results revealed a markedly elevated white blood cell count, with a predominance of neutrophils, suggesting an acute inflammatory response. The patient's CD4 count was critically low at 150 cells/mm³, highlighting the severe immunocompromised state due to HIV, which significantly increases the risk of disseminated tuberculosis. Sputum samples were positive for acid-fast bacilli, confirming active pulmonary tuberculosis. Additionally, arterial blood gas analysis showed severe hypoxemia with a PaO2 of 55 mmHg, a PaCO2 of 45 mmHg, and a pH of 7.35, indicating compensated respiratory acidosis. Radiographic imaging displayed multiple cavitary lesions in both lungs, significant consolidation, and evidence of miliary spread.

In response to the critical findings, the medical team initiated antitubercular therapy using a regimen of isoniazid, rifampin, ethambutol, and pyrazinamide, while carefully monitoring for potential drug interactions with his antiretroviral therapy. Despite these interventions, the patient's condition deteriorated with episodes of massive hemoptysis, suggesting a possible rupture of a cavity into a bronchus. This complication necessitated an urgent shift in management strategy, including the consideration of bronchial artery embolization to control bleeding and prevent further respiratory compromise. The unfolding complexity of this case demands advanced clinical judgment to prioritize interventions, manage complications, and prevent further deterioration.

Section 2

As the healthcare team monitored the patient's response to the interventions, new complications emerged that demanded immediate attention. Despite the initiation of antitubercular therapy and supportive care, the patient's respiratory status continued to decline. The patient experienced increased episodes of hemoptysis, with each event more severe than the last, contributing to further respiratory compromise and hemodynamic instability. Vital signs indicated a heart rate of 130 bpm, respiratory rate of 36 breaths per minute, and blood pressure dropping to 85/55 mmHg, signaling potential hypovolemic shock from blood loss. The patient also exhibited increased confusion and agitation, indicative of worsening hypoxemia and decreased cerebral perfusion.

In light of these developments, a repeat chest CT scan was performed, revealing progression of the cavitary lesions with new areas of consolidation and bronchial artery enlargement, suggesting active bleeding sites. The decision was made to proceed with urgent bronchial artery embolization to control the massive hemoptysis. Collaboration with interventional radiology was crucial to coordinate this life-saving procedure. Meanwhile, aggressive fluid resuscitation and transfusion of packed red blood cells were initiated to stabilize hemodynamics and improve oxygen-carrying capacity.

Post-embolization, the patient's bleeding was controlled, but the underlying respiratory distress persisted. Arterial blood gas analysis post-procedure showed a PaO2 of 60 mmHg, PaCO2 of 50 mmHg, and pH of 7.30, indicating worsening respiratory acidosis. This prompted the initiation of non-invasive ventilation to support breathing and improve gas exchange. As the team continued to balance the complex interplay of tuberculosis management, HIV care, and acute respiratory failure, they remained vigilant for signs of further deterioration or additional complications, such as acute respiratory distress syndrome (ARDS), necessitating ongoing critical evaluation and adjustment of the treatment plan.

Section 3

As the healthcare team continued to manage the complex clinical picture, a new complication emerged: acute kidney injury (AKI). The patient's urine output had noticeably decreased to less than 200 mL over the past 12 hours, raising concerns about renal perfusion. Laboratory tests confirmed the suspicion of AKI, revealing elevated serum creatinine levels of 3.2 mg/dL and blood urea nitrogen (BUN) of 45 mg/dL, significantly higher than baseline. Electrolyte imbalances were also noted, with hyperkalemia showing a potassium level of 5.8 mmol/L, necessitating urgent correction to prevent cardiac complications.

The renal team was consulted to evaluate the need for renal replacement therapy, given the patient's hemodynamic instability and the risk of further metabolic derangements. In the meantime, the primary focus was on optimizing fluid management, balancing the need to prevent fluid overload due to compromised respiratory function with the necessity of maintaining adequate renal perfusion. Adjustments to the patient's medication regimen were made to minimize nephrotoxic potential while ensuring continued effective antitubercular and supportive therapy.

Throughout this period, the patient's mental status fluctuated, with episodes of delirium becoming more pronounced. Continuous monitoring was essential to assess the effectiveness of interventions and to detect early signs of worsening renal or respiratory status. The multidisciplinary team, including critical care specialists, nephrologists, and infectious disease experts, remained in constant communication, adapting the treatment plan as new information became available. These developments highlighted the importance of precise clinical reasoning and advanced judgment in navigating the intertwined complexities of the patient's condition.

Section 4

The patient's condition took a further turn when new diagnostic results revealed a concerning progression in the pulmonary aspect of the illness. A recent chest X-ray and CT scan exhibited worsening bilateral infiltrates, indicative of advancing pulmonary tuberculosis despite ongoing treatment. This was accompanied by a marked decline in oxygen saturation levels, dropping to 85% on room air, necessitating an increase in supplemental oxygen support. Arterial blood gas analysis showed a pH of 7.28, PaCO2 of 55 mmHg, and PaO2 of 60 mmHg, confirming a mixed respiratory and metabolic acidosis, likely exacerbated by the underlying renal impairment and impaired gas exchange.

In light of these findings, the healthcare team faced the critical task of reassessing the patient's respiratory support strategy. The decision to initiate non-invasive positive pressure ventilation was made to improve alveolar ventilation and oxygenation without further compromising renal perfusion through aggressive fluid shifts. Concurrently, adjustments to the anti-tubercular regimen were considered, exploring the possibility of drug-resistant strains or the need for alternative medications that would not exacerbate renal or hepatic function. The patient's nutritional support also required careful re-evaluation to ensure adequate caloric intake while managing electrolyte imbalances.

As the team navigated these challenges, the patient's mental status continued to fluctuate, raising concerns about the potential for hypoxic brain injury or septic encephalopathy. Neuroimaging was contemplated to rule out any central nervous system involvement by the mycobacterial infection. This period underscored the critical need for vigilant monitoring and rapid adaptation of the therapeutic approach, relying heavily on precise clinical reasoning and advanced judgment to steer the patient through this complex and precarious phase of their illness.

Section 5

The healthcare team decided to proceed with neuroimaging to assess the potential for central nervous system involvement or hypoxic brain injury, as the patient's fluctuating mental status remained a significant concern. The MRI results revealed signs of early diffuse cerebral edema, suggesting the possibility of hypoxic insult rather than tubercular meningitis, as no meningeal enhancement was observed. Meanwhile, the patient's laboratory results showed further deterioration in renal function, with serum creatinine levels rising to 3.2 mg/dL and blood urea nitrogen climbing to 55 mg/dL, indicating a worsening acute kidney injury likely compounded by the ongoing treatment regimen.

In response to these findings, the healthcare team initiated a meticulous balance of interventions aimed at managing the patient's complex condition. Diuretics were cautiously titrated to manage fluid overload without exacerbating the renal impairment, and continuous renal replacement therapy was considered as a potential step if renal function continued to decline. The anti-tubercular regimen was adjusted to exclude nephrotoxic agents, and alternative medications were introduced based on sensitivity testing that revealed resistance to isoniazid and rifampin. Additionally, the patient's nutritional plan was modified to include renal-friendly options with electrolyte monitoring, ensuring adequate energy provision while preventing further metabolic derangement.

As these interventions unfolded, the patient's response was carefully monitored. The initiation of non-invasive positive pressure ventilation showed promising signs, with a gradual improvement in oxygen saturation levels to 92% on supplemental oxygen. However, the challenge of maintaining mental status stability persisted, necessitating frequent neurological assessments. The healthcare team remained vigilant, ready to adapt the treatment plan as new information emerged, emphasizing the need for ongoing collaboration and critical analysis to navigate this intricate clinical scenario effectively.